The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

BEGONIA: Phase 1b/2, open-label, platform study of the safety and efficacy of durvalumab (D) ± paclitaxel (P) with novel oncology therapies for first-line metastatic triple-negative breast cancer (mTNBC): Addition of arm 7, D + datopotamab deruxtecan (Dato-DXd; DS-1062).

Peter  Schmid

Employment - Roche (I)

Honoraria - AstraZeneca; Novartis; Pfizer; Roche

Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche; Merck; Novartis; Pfizer; Puma Biotechnology

Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Novartis (Inst); OncoGenex (Inst); Roche (Inst)

Ana Tablante  Nunes

Employment - AstraZeneca

Hannah  Dry

Employment - AstraZeneca

Rachel  Dougherty

Employment - AstraZeneca

Vatsala  Karwe

Employment - AstraZeneca

Urban J.  Scheuring

Employment - AstraZeneca